{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:15:06Z","timestamp":1774908906657,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Asociaci\u00f3n Ginecologica 12 Octubre.","award":["04\/ENDO\/2016"],"award-info":[{"award-number":["04\/ENDO\/2016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3484-1","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T09:00:29Z","timestamp":1501059629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vaginal metastasis as the initial presentation of leiomyosarcoma: a case report"],"prefix":"10.1186","volume":"17","author":[{"given":"Cecilia","family":"Villala\u00edn-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Tejerizo-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Lopez-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregorio","family":"L\u00f3pez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma. Reyes","family":"Oliver-Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7286-8656","authenticated-orcid":false,"given":"Jes\u00fas S.","family":"Jim\u00e9nez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,26]]},"reference":[{"key":"3484_CR1","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/0284186X.2012.689111","volume":"51","author":"CG Trop\u00e9","year":"2012","unstructured":"Trop\u00e9 CG, Abeler VM, Kristensen GB. Diagnosis and treatment of sarcoma of the uterus: a review. Acta Oncol. 2012;51:694.","journal-title":"Acta Oncol"},{"key":"3484_CR2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2559.2009.03231.x","volume":"54","author":"VM Abeler","year":"2009","unstructured":"Abeler VM, Royne O, Thorensen S, et al. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000, including 419 patients. Histopathology. 2009;54:355\u201364.","journal-title":"Histopathology"},{"key":"3484_CR3","first-page":"131","volume":"116","author":"E D'Angelo","year":"2010","unstructured":"D'Angelo E, Prat J. Uterine Sarcomas. GynecolOncol. 2010;116:131\u20139.","journal-title":"GynecolOncol"},{"key":"3484_CR4","first-page":"277","volume":"106","author":"FIGO commitee on gynecologic Oncology","year":"2009","unstructured":"FIGO commitee on gynecologic Oncology. FIGO staging for uterine sarcomas. Int J GynObst 2009; 104:179. And corrigendum to \u201cFIGO staging for uterine sarcomas\u201d. Int J GynObst. 2009;106:277.","journal-title":"Int J GynObst"},{"issue":"3","key":"3484_CR5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0090-8258(03)00137-9","volume":"89","author":"RL Giuntoli 2nd","year":"2003","unstructured":"Giuntoli RL 2nd, Metzinger DS, DiMarco CS, et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003;89(3):460-9.","journal-title":"Gynecol Oncol"},{"key":"3484_CR6","doi-asserted-by":"crossref","unstructured":"Amant F, Coosemans A, Renard V, Everaert E, Vergote I.Clinical outcome of ET-743 (Trabectedin; Yondelis) in high-grade uterine sarcomas: report on five patients and a review of the literature. Int J Gynecol Cancer. 2009;19(2):245\u20138.","DOI":"10.1111\/IGC.0b013e31819c0f59"},{"issue":"4","key":"3484_CR7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3892\/mco.2013.124","volume":"1","author":"H Kobayashi","year":"2013","unstructured":"Kobayashi H, Uekuri C, et al. The biology of uterine sarcomas: a review and update. Mol Clin Oncol. 2013;1(4):599\u2013609.","journal-title":"Mol Clin Oncol"},{"issue":"5","key":"3484_CR8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/PAS.0b013e3182893f36","volume":"37","author":"A Ly","year":"2013","unstructured":"Ly A, Mills AM, et al. Atypical Leiomyomas of the uterus. A clinicopathologic study of 51 Cases. Am J Surg Pathol. 2013;37(5):643\u20139.","journal-title":"Am J Surg Pathol"},{"key":"3484_CR9","doi-asserted-by":"publisher","unstructured":"D'Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2009. doi: 10.1016\/j.ygyno.2009.09.023 .","DOI":"10.1016\/j.ygyno.2009.09.023"},{"issue":"3","key":"3484_CR10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/PGP.0b013e318200caff","volume":"30","author":"VM Abeler","year":"2011","unstructured":"Abeler VM, Nenodovic M. Diagnostic immunohistochemistry in uterine sarcomas: a study of 397 cases. Int J Gynecol Pathol. 2011;30(3):236\u201343.","journal-title":"Int J Gynecol Pathol"},{"key":"3484_CR11","unstructured":"Oncogu\u00eda SEGO: Sarcomas uterinos. Gu\u00edas de pr\u00e1ctica cl\u00ednica en c\u00e1ncer ginecol\u00f3gico y mamario: Publicaciones SEGO; Gynecol Oncol. 2003;89(3):460\u20139."},{"key":"3484_CR12","doi-asserted-by":"crossref","first-page":"10022","DOI":"10.1200\/jco.2011.29.15_suppl.10022","volume":"S","author":"P Pautier","year":"2011","unstructured":"Pautier P, Floquet A, Berton-Rigaud D, Piperno-Neumann S. A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin in localized uterine sarcomas: results from 81 randomized patients (abstract 10022). J Clin Oncol. 2011;S:10022.","journal-title":"J Clin Oncol"},{"issue":"5","key":"3484_CR13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00004728-200309000-00020","volume":"27","author":"V Cantisani","year":"2003","unstructured":"Cantisani V, Mortele KJ, et al. Vaginal metastasis from uterine leiomyosarcoma. Magnetic resonance imaging features with pathological correlation. J Comput Assist Tomogr. 2003;27(5):805\u20139.","journal-title":"J Comput Assist Tomogr"},{"issue":"1","key":"3484_CR14","first-page":"28","volume":"17","author":"M Carmen Binda del","year":"2010","unstructured":"del Carmen Binda M, Cejas C, et al. Leiomiosarcoma uterino con met\u00e1stasis vaginal A prop\u00f3sito de un caso. Revista Argentina de Radiolog\u00eda. 2010;17(1):28\u201331. vol. 70, n\u00fam. 3, julio-septiembre, 2006, pp. 207-212","journal-title":"Revista Argentina de Radiolog\u00eda"},{"issue":"50","key":"3484_CR15","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1073\/pnas.0808188105","volume":"105","author":"SD Peddada","year":"2008","unstructured":"Peddada SD, Laughlin SK, Miner K, et al. Growth of uterine leiomyomata among premenopausal black and white women. ProcNatlAcadSci USA. 2008;105(50):1987.","journal-title":"ProcNatlAcadSci USA"},{"key":"3484_CR16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00261-012-9919-x","volume":"38","author":"SH Tirumani","year":"2013","unstructured":"Tirumani SH, Ojili V, Shanbhogue AKP, et al. Current concepts in the imaging of uterine sarcoma. Abdom Imaging. 2013;38:397\u2013411.","journal-title":"Abdom Imaging"},{"key":"3484_CR17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00000478-199406000-00001","volume":"18","author":"SW Bell","year":"1994","unstructured":"Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994;18:535.","journal-title":"Am J Surg Pathol"},{"key":"3484_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2004.11.009","volume":"161","author":"AA Sandberg","year":"2005","unstructured":"Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyosarcoma. Cancer Genet Cytogenet. 2005;161:1.","journal-title":"Cancer Genet Cytogenet"},{"issue":"4","key":"3484_CR19","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.23245","volume":"112","author":"DS Kapp","year":"2008","unstructured":"Kapp DS, Shin JY. Chan JK prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer. 2008;112(4):820.","journal-title":"Cancer"},{"key":"3484_CR20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ygyno.2007.02.031","volume":"106","author":"RL Giuntoli 2nd","year":"2007","unstructured":"Giuntoli RL 2nd, Garrett-Mayer E, Bristow RE, Gostout BS. Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma. Gynecol Oncol. 2007;106:82\u20138.","journal-title":"Gynecol Oncol"},{"key":"3484_CR21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00313020601136146","volume":"39","author":"F Moinfar","year":"2007","unstructured":"Moinfar F, Azodi M, Tavassoli FA. Uterine sarcomas. Pathology. 2007;39:55.","journal-title":"Pathology"},{"issue":"218","key":"3484_CR22","first-page":"e1","volume":"198","author":"SM Ueda","year":"2008","unstructured":"Ueda SM, Kapp DS, Cheung MK, et al. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol. 2008;198(218):e1.","journal-title":"Am J Obstet Gynecol"},{"key":"3484_CR23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/cncr.11484","volume":"98","author":"ME Sherman","year":"2003","unstructured":"Sherman ME, Devesa SS. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer. 2003;98:176.","journal-title":"Cancer"},{"issue":"12","key":"3484_CR24","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1470-2045(09)70226-8","volume":"10","author":"F Amant","year":"2009","unstructured":"Amant F, Coosemans A, Debiec-Rychter M, Timmerman D, Vergote I. Clinical management of uterine sarcomas. Lancet Oncol. 2009;10(12):1188\u201398.","journal-title":"Lancet Oncol"},{"key":"3484_CR25","first-page":"36","volume":"22","author":"JH Nam","year":"2010","unstructured":"Nam JH, Park JY. Update on treatment of uterine sarcoma. CurrOpinObstet Gynecol. 2010;22:36\u201342.","journal-title":"CurrOpinObstet Gynecol"},{"key":"3484_CR26","doi-asserted-by":"crossref","unstructured":"Seddon B, Whelan J, Strauss SJ, Leahy MG. GeDDiS: a prospective randomised controlled phase III trial of gemcitabine and docetaxel compared with doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft tissue sarcomas (EudraCT 2009-014907-29). J Clin Oncol. 2015;33(S1):abstract 10500","DOI":"10.1200\/jco.2015.33.15_suppl.10500"},{"key":"3484_CR27","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ejca.2008.01.019","volume":"44","author":"NS Reed","year":"2008","unstructured":"Reed NS, Mangioni C, Malmstr\u00f6m H, et al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological cancer group study (protocol 55874). Eur J Cancer. 2008;44:808.","journal-title":"Eur J Cancer"},{"key":"3484_CR28","first-page":"CD006812","volume":"1","author":"K Galaal","year":"2011","unstructured":"Galaal K, Godfrey K, Naik R, et al. Adjuvant radiotherapy and\/or chemotherapy after surgery for uterine carcinosarcoma. Cochrane Database Syst Rev. 2011;1:CD006812.","journal-title":"Cochrane Database Syst Rev"},{"key":"3484_CR29","doi-asserted-by":"crossref","unstructured":"Garcia C. Kubat JS clinical outcomes and prognostic markers in uterine leiomyosarcoma: a population-based cohort. Int J Gynecol Cancer. 2015;25(4):622\u20138.","DOI":"10.1097\/IGC.0000000000000370"},{"issue":"3","key":"3484_CR30","first-page":"2795","volume":"8","author":"MM Allen","year":"2015","unstructured":"Allen MM, Douds JJ. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas. Int J Clin Exp Pathol. 2015;8(3):2795\u2013801.","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"3484_CR31","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.humpath.2013.11.003","volume":"45","author":"B Davidson","year":"2014","unstructured":"Davidson B, Abeler VM. Gene expression signatures of primary and metastatic uterine leiomyosarcoma. Hum Pathol. 2014;45(4):691\u2013700.","journal-title":"Hum Pathol"},{"issue":"9","key":"3484_CR32","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/jclinpath-2015-202915","volume":"68","author":"H Hwang","year":"2015","unstructured":"Hwang H, Matsuo K. Immunohistochemical panel to differentiate endometrial stromal sarcoma, uterine leiomyosarcoma and leiomyoma: something old and something new. J Clin Pathol. 2015;68(9):710\u20137.","journal-title":"J Clin Pathol"},{"key":"3484_CR33","volume-title":"WHO Classification of tumours of female reproductive organs","author":"RJ Kurman","year":"2014","unstructured":"Kurman RJ, Carcangiu ML, Simon Herrington C, Young RH. WHO Classification of tumours of female reproductive organs. Lyon: IARC; 2014."},{"key":"3484_CR34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ygyno.2016.01.001","volume":"140","author":"Y Ravid","year":"2016","unstructured":"Ravid Y, Formanski M, Smith Y, et al. Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signatures. Gynecol Oncol. 2016;140:512\u20137.","journal-title":"Gynecol Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3484-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T12:38:02Z","timestamp":1569933482000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3484-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,26]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3484"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3484-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,26]]},"article-number":"503"}}